|
|
Adherence to HIV Regimens: Research
- Researchers Develop Breath-Monitoring Device to Monitor Treatment Adherence Among HIV-Positive People (April 23, 2008)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Among Patients on Boosted-PI Regimens, Dose Staggering and Selective Non-Adherence to Ritonavir Is Relatively Common (February 6, 2008)
From The Body PRO
- HIV-Positive People With Depression More Likely to Follow Treatment Regimens When Taking SSRIs, Study Finds (January 8, 2008)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Effects of Adherence Support Programmes May Be Short Lived (January 2, 2008)
From aidsmap.com
- Consequences of Non-Adherence Worse in African-Americans Than White People (December 16, 2007)
From aidsmap.com
- Adherence to HIV Treatment Linked to Health Literacy, Study Finds (November 19, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Once-Daily Nevirapine Doesn't Improve Adherence, May Increase Risk of Treatment Break and Resistance (October 26, 2007)
From aidsmap.com
- Pillboxes Should Be Standard Issue for HIV Patients, Study Concludes (September 10, 2007)
From aidsmap.com
- Lower Adherence May Precede Viral Load "Blips" (September 28, 2006)
In 46th Interscience Conference on Antimicrobial Agents and Chemotherapy
- Higher Degree of Medication "Forgiveness" in Use of Boosted Protease Inhibitors (August 15, 2006)
In The XVI International AIDS Conference
- HIV JournalView: Adherence, Viral Fitness and NNRTI and PI Resistance (February/March 2006)
Bangsberg et al find that NNRTIs are more likely to suppress HIV than a single PI, but are also more vulnerable to resistance at low adherence levels.
From The Body PRO
- Industry-Sponsored Study Examines Factors Influencing Adherence (Winter 2005/2006)
The demands of life and work are the biggest obstacles to perfect adherence, HIVers say.
To read PDF, click here
In Body Positive, from Body Positive
- Literature Review: Antidepressant Treatment Improves Adherence to Antiretrovirals (January 2006)
In Infectious Diseases in Corrections Report, from Brown Medical School
- Adherence in the Developing World: It's Not Just About the Meds (December 2005)
Harvard University professor Arachu Castro discusses the roles that biology, society and poverty play in determining the adherence levels of HIV-infected people in resource-poor countries.
In PLoS Medicine
- New Device Offers Friendly Medication Reminder to HIV Patients (October 12, 2005)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Couple-Focused Support Improves HIV Medication Adherence (August 24, 2005)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Use of and Adherence to Antiretroviral Therapy Is Associated With Decreased Sexual Risk Behavior in HIV Clinic Patients (August 10, 2005)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- The Link Between Unsafe Sex, Poor HAART Adherence, Resistance and Drug Resistant HIV Transmission (July 25, 2005)
In The 3rd International AIDS Society Conference on HIV Pathogenesis and Treatment
- Adherence to Antiretroviral Therapy Among Substance Users (June 2005)
Guidelines from the New York State Department of Health AIDS Institute.
To read PDF, click here
From New York State Department of Health
- HIV and Depression: Antidepressant Use Improves HAART Adherence (March 17, 2005)
This study finds that clinically depressed HIVers who receive antidepressants are more likely to adhere to their HIV medications.
From aidsmap.com
- Is 80%-90% Adherence the Best Predictor of Drug Failure? (February/March 2005)
A study suggests that resistance risk is highest for people who have good, but not great, treatment adherence.
From The Body PRO
- NNRTI Resistance Occurs More Often at Lower Levels of Adherence Than Does PI Resistance (July 14, 2004)
In The XV International AIDS Conference, from The Body PRO
- Adherence Conference: Elements of Success (March/April 2004)
Highlights from the 2nd International Conference on Adherence to Antiretroviral Therapy (December 4-7, 2003).
To read PDF, click here
In Positively Aware, from Test Positive Aware Network
- Adherence, not Baseline CD4 Cell Count, Linked to CD4 Cell Gain on HAART (February 25, 2004)
New support for those who feel treatment should be delayed until a patient's CD4 cell count falls near 200.
From aidsmap.com
- HIV Treatment Education Program Beneficial for Adherence, Health of HAART Patients (January 23, 2004)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Adherence and HIV Drug Resistance (January 2004)
"Near-perfect" adherence to a powerful HAART regimen appears to be the best way to avoid developing drug-resistant HIV.
In Hopkins HIV Report
- HAART Often Successful in HIV/HCV Coinfected Patients -- If They Can Stay on Treatment (September 15, 2003)
In The 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, from The Body PRO
- HIV-Positive Brazilian Women Find Adherence Hard (September 15, 2003)
From aidsmap.com
- African HIV/AIDS Patients Show Better Adherence to Antiretroviral Drug Regimens Than U.S. Counterparts (September 3, 2003)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Resistance Still Possible Despite Perfect Adherence, Study Says (August 28, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Adherence to HIV Antiretrovirals Among Persons With Serious Mental Illness (August 11, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Keys to Adherence in Youth: Simplicity, Knowledge, Support (August 7, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- U.S. Teen HIV Prevention, HAART Adherence Programs Examined (August 5, 2003)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Better Suppression, Adherence With Once-Daily FTC/ddI/Efavirenz Than Most PI-Based Regimens (July 14, 2003)
In The 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment, from The Body PRO
- Simplification Works! Fewer Pills Mean Better Adherence and Quality of Life (July 14, 2003)
In The 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment, from The Body PRO
- Doubts About DOT: Antiretroviral Therapy for Resource-Poor Countries (July 8, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- South Africa: HIV Treatment Adherence as High as Developed World (July 7, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Assessment of Changes in Adherence and Quality of Life After the Simplification of Antiretroviral Treatment (July 2003)
Highlights from the IAPAC Sessions 2003.
To read PDF, click here
In IAPAC Monthly, from International Association of Physicians in AIDS Care
- New Initiative Aims to Increase HAART Adherence (June 25, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Study Details Link Between Attitude, Adherence (April 30, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Starting Therapy and Adherence: Moving Beyond Pill Boxes and Timers (April 28, 2003)
From Canadian AIDS Treatment Information Exchange
- Relationship of Gender, Depression, and Health Care Delivery With Antiretroviral Adherence in HIV-Infected Drug Users (April 2003)
In Journal of General Internal Medicine
- DAAT May Work Where DOT Model Fell Short (February 5, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Baltimore: HIV Medication -- Patients Get Someone to Watch Over Them (February 3, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Directly Administered Antiretroviral Therapy in the Treatment of HIV Infection: Benefit or Burden? (January 27, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Plasma Protease Inhibitor Levels Can Mark Nonadherence (January 23, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Simpler Therapy Can Help HIV Patients (December 26, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Directly-Observed Therapy in HIV-Positive Heroin Users (December 20, 2002)
From Canadian AIDS Treatment Information Exchange
- Therapy Adherence and Highly Active Antiretroviral Therapy: Comparison of Three Sources of Information (December 16, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Depression Is a Risk Factor for Suboptimal Adherence to Highly Active Antiretroviral Therapy (December 15, 2002)
In Journal of Acquired Immune Deficiency Syndromes
- Perception of Punishment Undermines Adherence (November 27, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Mediators of Social Support and Antiretroviral Adherence Among an Indigent Population in New York City (November 14, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Report on Adherence From the XIV International AIDS Conference in Barcelona (November 2002)
In Hopkins HIV Report
- Intentional Nonadherence to HAART Common Due to Side Effects, Study Finds (October 31, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Adherence Intervention Project Linked to Lower Viral Load (October 28, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Potential Impact of Once-Daily Regimens on Adherence to HAART (October 26, 2002)
In 40th Annual Meeting of the Infectious Diseases Society of America, from The Body PRO
- For HIV-Positive People, Too Much Optimism May Be Dangerous (October 9, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- New York: HIV Patients' Drug Regimens Upset by September 11th (September 11, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Durability and Predictors of Success of Highly Active Antiretroviral Therapy for Ambulatory HIV-Infected Patients (September 10, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- DOT for HAART: Directly Observed Therapy (Fall 2002)
To read PDF, click here
In STEP Perspective, from Seattle Treatment Education Project
- Internet Paging System Helps Improve Adherence (August 23, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Counseling Program Found to Benefit Newly Diagnosed HIV Patients (August 14, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Effects of Depressive Symptoms and Mental Health Quality of Life on Use of Highly Active Antiretroviral Therapy Among HIV-Seropositive Women (August 1, 2002)
In Journal of Acquired Immune Deficiency Syndromes
- Adherence to HAART Has Major Impact on Survival in HIV-Infected Patients (July 23, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Adherence Research Roundup From the International AIDS Conference (July 13, 2002)
In The XIV International AIDS Conference, from The Body PRO
- Highlights of Presentations on Gender From Barcelona (July 13, 2002)
Includes a review of research on women's adherence to HAART.
In The XIV International AIDS Conference, from The Body PRO
- Potency and Tolerability of Once-a-Day, Directly Observed Therapy for Inner-City, Minority Patients (July 9, 2002)
In The XIV International AIDS Conference, from The Body PRO
- Adherence to Combivir as Post-Exposure Prophylaxis in Non-Occupational HIV Exposures (July 8, 2002)
In The XIV International AIDS Conference, from The Body PRO
- Viral Blips and Virologic Failure (April 29, 2002)
Study results presented at Retrovirus 2002.
To read PDF, click here
In STEP Ezine, from Seattle Treatment Education Project
- Selected Highlights From Retrovirus: Adherence to Therapy (February 28, 2002)
In The 9th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Nevirapine and Protease Inhibitor-Based Regimens in a Directly Observed Therapy (DOT) Program for Intravenous Drug Users (February 26, 2002)
In The 9th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- An Examination of Social and Behavioral Factors Potentially Affecting Black Men's Ability to Adhere to HAART (February 13, 2002)
To read PDF, click here
In STEP Ezine, from Seattle Treatment Education Project
- Simplification of Protease Inhibitor-Containing HAART Regimen With Abacavir Maintains Viral Suppression and Favorable Adherence in HIV-1 Infected Adults (October 27, 2001)
In 39th Annual Meeting of the Infectious Diseases Society of America, from The Body PRO
- Limited Patient Adherence to Highly Active Antiretroviral Therapy for HIV-1 Infection in an Observational Cohort Study (September 10, 2001)
In Archives of Internal Medicine
- Spotlight: Telemedicine in Clinical Practice (June/July 2001)
To read PDF, click here
In HEPP News, from Brown Medical School
- A Comparison Study of Multiple Measures of Adherence to HIV Protease Inhibitors (May 15, 2001)
In Annals of Internal Medicine
- Impact of Directly-Observed Therapy on Long-Term Outcomes in HIV Clinical Trials (February 7, 2001)
In The 8th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Adherence to HIV Therapy (2001)
From Forum for Collaborative HIV Research
- Highlights From the XIII International AIDS Conference: Adherence and Twice-Daily Dosing (Autumn 2000)
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- Patient Adherence With Twice-Daily Dosing of Nelfinavir Equivalent to NNRTIs When Given in Combination With Dual NRTIs (July 13, 2000)
In The XIII International AIDS Conference, from The Body PRO
- Self-Efficacy: Predictor of Adherence to Antiretroviral Medications (July 13, 2000)
In The XIII International AIDS Conference, from The Body PRO
- Study of Adherence to HAART in a Sample of HIV-Infected Patients (July 13, 2000)
In The XIII International AIDS Conference, from The Body PRO
- Low Frequency of Genotypic Resistance Markers in Therapy-Naive HIV+ Adolescents (July 11, 2000)
In The XIII International AIDS Conference, from The Body PRO
- Poorer Adherence to HAART and Risky Sex Behavior Within HIV-Serodiscordant Couples (July 11, 2000)
In The XIII International AIDS Conference, from The Body PRO
- Patient Adherence to Antiretroviral Therapies -- I (July 10, 2000)
In The XIII International AIDS Conference, from The Body PRO
- Feasibility Study of the Disease Management Assistance System: A Potential Adherence Enhancement Device (January 31, 2000)
In The 7th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Non-Compliance Often the Cause When AIDS Drugs "Fail" (January 22, 2000)
In British Medical Journal
- Taking a Break When All Else Fails (April 1999)
In GMHC Treatment Issues, from Gay Men's Health Crisis
- AIDS Researchers Target Poor Adherence (March 24, 1999)
In Journal of the American Medical Association
- Adherence Matters: Dose-Skipping Is Risky Business (February 1999)
In Positive Living, from AIDS Project Los Angeles
- Antiretroviral Therapy: Adherence and Quality of Life (February 1, 1999)
In The 6th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Obstacles to Treatment Success (October 1998)
In GMHC Treatment Issues, from Gay Men's Health Crisis
- The Perils of Discontinuing Therapy: Without HAART, Cytokines Stimulate HIV From Latently Infected Cells (July 6, 1998)
From U.S. National Institute of Allergy and Infectious Diseases
- Protease Inhibitors in the HIV+ Homeless and Marginally Housed: Good Adherence but Rarely Prescribed (July 1, 1998)
In The 12th International AIDS Conference, from The Body PRO
- Mutinous Rumblings of Pill Popping Public Prompts Drug Outfits' Focus on User-Friendly Dosing Schemes (June 1998)
In TAGline, from Treatment Action Group
- Mechanisms of Antiretroviral Therapy Failure: Adherence (May 1, 1998)
In The 8th Clinical Care Options for HIV Symposium, from The Body PRO
- Adhering to Complex Regimens for HIV (April 1998)
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Adherence and the HIV Community (January 1998)
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- Update on Adherence to HIV Therapy (January 1998)
In Hopkins HIV Report
|
|
